FR2361892B1 - - Google Patents

Info

Publication number
FR2361892B1
FR2361892B1 FR7638523A FR7638523A FR2361892B1 FR 2361892 B1 FR2361892 B1 FR 2361892B1 FR 7638523 A FR7638523 A FR 7638523A FR 7638523 A FR7638523 A FR 7638523A FR 2361892 B1 FR2361892 B1 FR 2361892B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7638523A
Other versions
FR2361892A1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Inc
Original Assignee
Pfizer Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Inc filed Critical Pfizer Inc
Publication of FR2361892A1 publication Critical patent/FR2361892A1/fr
Application granted granted Critical
Publication of FR2361892B1 publication Critical patent/FR2361892B1/fr
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C07D213/63—One oxygen atom
    • C07D213/64—One oxygen atom attached in position 2 or 6
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
FR7638523A 1976-01-20 1976-12-21 Esters et amides des acides pyrimido(4,5-b)quinolein-4(3h)-one-2-carboxyliques, en tant qu'agents anti-ulceres Granted FR2361892A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/650,714 US4011324A (en) 1976-01-20 1976-01-20 Esters and amides of pyrimido[4,5-b]quinolin-4(3H)-one-2-carboxylic acids as antiulcer agents

Publications (2)

Publication Number Publication Date
FR2361892A1 FR2361892A1 (fr) 1978-03-17
FR2361892B1 true FR2361892B1 (fr) 1980-09-19

Family

ID=24609991

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7638523A Granted FR2361892A1 (fr) 1976-01-20 1976-12-21 Esters et amides des acides pyrimido(4,5-b)quinolein-4(3h)-one-2-carboxyliques, en tant qu'agents anti-ulceres

Country Status (10)

Country Link
US (1) US4011324A (fr)
JP (2) JPS5289700A (fr)
BE (1) BE849647A (fr)
DE (1) DE2700216A1 (fr)
DK (1) DK575776A (fr)
FR (1) FR2361892A1 (fr)
GB (1) GB1531681A (fr)
IE (1) IE43964B1 (fr)
LU (1) LU76457A1 (fr)
NL (1) NL168515C (fr)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2757915A1 (de) * 1976-12-28 1978-07-06 Mitsubishi Yuka Pharma Pyrimidochinoxalinderivate, verfahren zur herstellung derselben und arzneimittel zur behandlung von allergischem asthma
DE3138550A1 (de) * 1981-09-28 1983-04-07 Boehringer Ingelheim KG, 6507 Ingelheim Substituierte 2-phenyl-2-(pyridyloxy)-ethylamine und isostere verbindungen, verfahren zu ihrer herstellung und verwendung
US4551460A (en) * 1982-05-10 1985-11-05 Hoffmann-La Roche Inc. Pyrido[2,1-b]quinazoline derivatives useful as agents for treatment of allergic conditions and vascular disorders involving thrombosis
DE3232620A1 (de) * 1982-09-02 1984-03-08 Hoechst Ag, 6230 Frankfurt 10-phenyl1-1,3,9-triazaanthracene und diese enthaltendes photopolymerisierbares gemisch
US6545004B1 (en) * 1999-10-27 2003-04-08 Cytokinetics, Inc. Methods and compositions utilizing quinazolinones
US7230000B1 (en) * 1999-10-27 2007-06-12 Cytokinetics, Incorporated Methods and compositions utilizing quinazolinones
JPWO2002094790A1 (ja) * 2001-05-23 2004-09-09 三菱ウェルファーマ株式会社 縮合ヘテロ環化合物およびその医薬用途
ITMI20012060A1 (it) * 2001-10-05 2003-04-05 Recordati Chem Pharm Nuovi eterocilcli n-acilati
EP1480980A4 (fr) * 2002-02-15 2005-04-20 Cytokinetics Inc Syntheses de quinazolinones
WO2003094839A2 (fr) * 2002-05-09 2003-11-20 Cytokinetics, Inc. Composes, compositions et procedes
EP1553931A4 (fr) 2002-05-09 2006-08-30 Cytokinetics Inc Composes, compositions et procedes
EP1513820A4 (fr) * 2002-05-23 2006-09-13 Cytokinetics Inc Composes, compositions et procedes
AU2003236527A1 (en) * 2002-06-14 2003-12-31 Cytokinetics, Inc. Compounds, compositions, and methods
WO2004009036A2 (fr) * 2002-07-23 2004-01-29 Cytokinetics, Inc. Composes, compositions et procedes
US20040048853A1 (en) * 2002-08-21 2004-03-11 Gustave Bergnes Compounds, compositions, and methods
WO2004034972A2 (fr) * 2002-09-30 2004-04-29 Cytokinetics, Inc. Composes, compositions, et procedes
EP1682534A2 (fr) * 2003-11-03 2006-07-26 Cytokinetics, Inc. Derives de pyrimidin-4-one, compositions et methodes
WO2005046588A2 (fr) * 2003-11-07 2005-05-26 Cytokinetics, Inc. Composes, compositions et methodes
JP2007513154A (ja) * 2003-12-08 2007-05-24 サイトキネティクス・インコーポレーテッド 化合物、組成物及び方法
ZA200609259B (en) 2004-04-30 2008-07-30 Takeda Pharmaceutical Heterocyclic amide compound and use thereof as an mmp-13 inhibitor

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3414574A (en) * 1967-04-21 1968-12-03 Sandoz Ag Certain pyrimido (4, 5-b) indoles and intermediates employed in their preparation
US3974161A (en) * 1974-02-20 1976-08-10 Pfizer Inc. Fused pyrimidin-4(3H)-ones as antiallergy agents
GB1458205A (en) * 1973-04-13 1976-12-08 Pfizer Fused pyrimidin-4- 3h-ones as antiallergy agents

Also Published As

Publication number Publication date
GB1531681A (en) 1978-11-08
NL168515B (nl) 1981-11-16
DK575776A (da) 1977-07-21
JPS5289700A (en) 1977-07-27
IE43964L (en) 1977-07-20
DE2700216A1 (de) 1977-07-28
NL7614191A (nl) 1977-07-22
LU76457A1 (fr) 1977-07-05
IE43964B1 (en) 1981-07-15
US4011324A (en) 1977-03-08
JPS5470433A (en) 1979-06-06
FR2361892A1 (fr) 1978-03-17
BE849647A (fr) 1977-06-20
NL168515C (nl) 1982-04-16

Similar Documents

Publication Publication Date Title
FR2361892B1 (fr)
FR2358841B1 (fr)
CH629926GA3 (fr)
JPS5737837B2 (fr)
JPS5739324Y2 (fr)
JPS5542914Y2 (fr)
JPS562585B2 (fr)
JPS5292906U (fr)
JPS5323671U (fr)
JPS5327550U (fr)
JPS5730591Y2 (fr)
JPS5622766B2 (fr)
JPS539417U (fr)
JPS5381173U (fr)
JPS52145258U (fr)
CS177447B1 (fr)
CS177441B1 (fr)
CH613906A5 (fr)
CH615800GA3 (fr)
CH614815A5 (fr)
CH614562A5 (fr)
CH614383A5 (fr)
CH604339A5 (fr)
DD120363A1 (fr)
CH613738A5 (fr)

Legal Events

Date Code Title Description
ST Notification of lapse